CA9 and gastric neoplasm: Some unique improvements were also noted, such as selective absorption of CRLX101 into gastric tumor tissue and reduced activity of potential drug targets such as carbonic anhydrase IX and HIF-1α in Chao et al. [48] and tumor downstaging in Sanoff et al. [45].